Chromosomal microarray better informs brain tumor diagnosis - Insights
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...
Christmas Specimen Shipping Guidelines and Schedule - Insights
Due to the Christmas holiday (recognized on Wednesday, Dec. 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...
Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...
Testing Archives - Page 24 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at newsbureau@mayo.edu, attention: Mayo Clinic Laboratories.
Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.
Testing Archives - Page 22 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 23 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
New tests launched in February - Insights
In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in February - Insights
In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.